News & Perspective

May 30, 2012

May 30, 2012

WHO hopes for meeting on dual-use research in late fall

(CIDRAP News) – The World Health Organization (WHO) hopes to hold a meeting late this fall to discuss "dual-use" research issues raised in the controversy over publication of two studies involving lab-modified H5N1 viruses with increased transmissibility, a WHO official said today.

May 10, 2012

May 10, 2012

House bill calls for White House biodefense advisor

(CIDRAP News) – A bill headed for the floor of the US House calls for appointing a special White House advisor to lead and coordinate biodefense activities, including developing a national biodefense plan and a biosurveillance strategy.

May 04, 2012

May 04, 2012

NIH rejects charge it slanted the H5N1 agenda for NSABB

(CIDRAP News) – In a lengthy letter, a National Institutes of Health (NIH) official has rejected recent charges that the agency planned a biased meeting agenda in an effort to induce the National Science Advisory Board for Biosecurity (NSABB) to act as it did in voting for full publication of two much-debated studies on H5N1 virus transmissibility.

May 03, 2012

May 03, 2012

Report details changes that may boost H5N1 spread in mammals

(CIDRAP News) – The first of two controversial H5N1 avian influenza studies to see print suggests that just four mutations in one of the virus's surface proteins may be enough to equip it to spread among mammals, but the findings are freighted with qualifiers.

May 01, 2012

May 01, 2012

NIH preparing tool to help labs cope with new DURC policy

(CIDRAP News) – Federal officials are working on guidance to help local institutions implement the government's new policy on the oversight of life-sciences dual-use research of concern (DURC), an official from the National Institutes of Health (NIH) said today.

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»